MedPath

Study to compare efficiency of two medicines namely levosimendan and milrinone in reducing pressure in pulmonary artery.

Phase 3
Completed
Conditions
Health Condition 1: I52- Other heart disorders in diseasesclassified elsewhere
Registration Number
CTRI/2019/01/017275
Lead Sponsor
one
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

1 Patients of either sex

2 Age betwwen 18 to 70 year

3 Mitral valve disease

4 Severe pulmonary hypertension (Right ventricular systolic pressure more than or equals to 50 mm Hg)

5 Scheduled for elective mitral valve replacement surgery

Exclusion Criteria

1 Presence of concurrent coronary artery disease. Patients more than 45yr old will have coronary angiography done to rule out coronary artery disease.

2 Coexisting aortic valve disease

3 Patients in NYHA IV

4 Patients requiring pre-operative inotropes

5 Pregnancy

6 Coexisting hepatic, renal or severe respiratory disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath